Medication info
Boniva 150 mg (Ibandronate Sodium Hydrate)

Boniva 150 mg (Ibandronate Sodium Hydrate)

Prescription medicationTabletOral
Ingredient · strength
Ibandronate Sodium Monohydrate›168.75mg / 1 tablet
Manufacturer / importer
Hybeast Pharmaceutical Co., Ltd.
Appearance
White oblong film-coated tablet
Packaging
1 tablet (1 tablet/PTP*1)
Approval status
Active

MFDS item code 201500856 · Approved 2015.02.16 · Insurance code 628800520

Summary

Main use
Treatment of osteoporosis in postmenopausal women
Who takes it
Adults · Children
Adult dose
Take 1 tablet once a month, regularly on the same day each month in the morning, with a sufficient amount of water, at least 1 hour before consuming food, beverages (other than water), or other oral medications or dietary supplements (including calcium): - This medicine should be swallowed with a sufficient amount of water (180-240ml) while standing or sitting upright, and you should not lie down for 60 minutes after taking it. - Mineral water may reduce the absorption of this medicine, so take it with plain water. - To avoid esophageal ulcers, do not chew or suck the tablet. If the patient forgets to take the medicine on the scheduled day - If there are more than 8 days until the next scheduled dose, take 1 tablet the morning after realizing that you missed the dose, and thereafter take 1 tablet each month on the previously scheduled dosing day. - If there are 7 days or fewer until the next scheduled dose, take 1 tablet on the next scheduled dosing day, and thereafter take 1 tablet each month on the previously scheduled dosing day. - Do not take 2 tablets in the same week. Patients whose dietary intake is inadequate should take supplements such as calcium or vitamin D. Patients with hepatic impairment No dosage adjustment is necessary. Patients with renal impairment No dosage adjustment is necessary for patients with mild or moderate renal impairment whose creatinine clearance is 30mL/min or higher. Use of this medicine is not recommended in patients with creatinine clearance below 30mL/min because clinical experience is insufficient. Older adults No dosage adjustment is necessary.
Child dose
Efficacy and safety in children 18 years of age or younger have not been studied.

Ingredients

Manufacturer
Hybeast Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of osteoporosis in postmenopausal women

  • Osteoporosis
View approved original text

This medication is used for the treatment of osteoporosis occurring in postmenopausal women. Osteoporosis is a condition characterized by decreased bone density, increasing the risk of fractures, and is particularly common in postmenopausal women. This drug helps to increase bone strength, reduce the risk of fractures, and maintain bone health. Thus, it is effective in preventing and treating osteoporosis caused by menopause.

How to take

Adult dose

Take 1 tablet once a month, regularly on the same day each month in the morning, with a sufficient amount of water, at least 1 hour before consuming food, beverages (other than water), or other oral medications or dietary supplements (including calcium): - This medicine should be swallowed with a sufficient amount of water (180-240ml) while standing or sitting upright, and you should not lie down for 60 minutes after taking it. - Mineral water may reduce the absorption of this medicine, so take it with plain water. - To avoid esophageal ulcers, do not chew or suck the tablet. If the patient forgets to take the medicine on the scheduled day - If there are more than 8 days until the next scheduled dose, take 1 tablet the morning after realizing that you missed the dose, and thereafter take 1 tablet each month on the previously scheduled dosing day. - If there are 7 days or fewer until the next scheduled dose, take 1 tablet on the next scheduled dosing day, and thereafter take 1 tablet each month on the previously scheduled dosing day. - Do not take 2 tablets in the same week. Patients whose dietary intake is inadequate should take supplements such as calcium or vitamin D. Patients with hepatic impairment No dosage adjustment is necessary. Patients with renal impairment No dosage adjustment is necessary for patients with mild or moderate renal impairment whose creatinine clearance is 30mL/min or higher. Use of this medicine is not recommended in patients with creatinine clearance below 30mL/min because clinical experience is insufficient. Older adults No dosage adjustment is necessary.

Child dose

Efficacy and safety in children 18 years of age or younger have not been studied.

Precautions

This medication should not be used in certain patients. For example, individuals with an allergy to this drug or its components, untreated hypocalcemia, those who cannot sit or stand upright for more than 60 minutes, patients with esophageal function problems affecting the passage of food, and individuals with lactose intolerance or related genetic disorders should not take this medication. For patients with severe renal failure, this medication should be administered with caution. Hypocalcemia or bone and mineral metabolic disorders must be treated before taking this drug, and it is important to consume adequate calcium and vitamin D. This medication can irritate the gastric mucosa, so patients with upper gastrointestinal conditions such as gastritis, esophagitis, or duodenitis should exercise caution. It is essential to strictly follow the prescribed method and dosages, and if there are difficulties swallowing, pain while swallowing, chest pain, or heartburn, take the medication immediately and consult a physician. During dental treatment or if oral health is poor, there is a risk of osteonecrosis of the jaw, so it is advisable to undergo oral examination and avoid excessive dental treatment prior to taking this medication. This medication may interfere with the absorption when taken with food or products containing calcium, aluminum, magnesium, iron, etc., so do not consume other food or drugs for at least 1 hour after taking it. Women who are pregnant or breastfeeding are advised not to use this medication, and safety and efficacy have not been established in children under 18 years of age. While taking this medication, rare side effects such as muscle pain, joint pain, headache, dyspepsia, nausea, diarrhea, and rash may occur, and in severe cases, allergic reactions or eye inflammation, atypical fractures have been reported. Overdosing may cause gastrointestinal disturbances or hypocalcemia, so caution is needed when taking this medication, and inducing vomiting is not recommended. Patients should remain seated or standing. Keep out of reach of children, and unused medication should be disposed of in an environmentally safe manner to prevent pollution.

Side effects

Dyspepsia, nausea, abdominal pain, diarrhea, bloating, gastroesophageal reflux disease, headache, influenza-like illness, fatigue, myalgia, arthralgia, rash, gastritis, esophagitis, muscle cramps, musculoskeletal pain, musculoskeletal stiffness, dysphagia, vomiting, esophageal ulcer, esophageal stricture, dizziness, low back pain, duodenitis, hypersensitivity reaction, angioedema, facial swelling, urticaria, uveitis, scleritis, osteonecrosis of the jaw and external auditory canal, anaphylactic reaction, shock, allergic reaction, Stevens-Johnson syndrome, erythema multiforme, vesicular dermatitis, atypical subtrochanteric and femoral neck fracture, atypical fracture of the pelvis, abnormal sensations in the eye, weakness, pruritus

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture. It is important to maintain a storage temperature between 1 to 30 degrees Celsius.

Appearance and packaging

Appearance

White oblong film-coated tablet

Package unit

1 tablet (1 tablet/PTP*1)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.